21-Mar-17 Israel's EyeYon Medical has raised USD6.5 mn to develop, test, and seek regulatory approval for its two main solutions: EndoArt, an artificial endothelial layer which can replace the need for cadaver based implants, and Hyper CLTM, a therapeutic soft contact lens. The investment was led by China-based VC Rimonci Capital and Gauss Group, with existing investors Triventures and Pontifax. [image: Globes]

15-Mar-17 China could prevent three million premature deaths each year by enforcing tighter air quality standards and reducing particulate matter to the level recommended by the WHO. Air pollution appears to have a much greater impact on deaths due to cardiorespiratory diseases, such as asthma and chronic lung disease (COPD), than it does on deaths due to other causes. [image: ET Healthworld]

14-Mar-17 Alex Gorsky, CEO of Johnson & Johnson said: "We believe that the macro trends - a large population, urbanisation, growing middle class, demand for healthier lifestyles and care choices - remain favourable for... China's healthcare industry. J&J has a legacy of translating technological innovation and medical science breakthroughs into industrial outputs that address the needs of patients and consumers." [image: China Daily]

13-Mar-17 A classic internet land grab is underway in China, with over 2,000 well-funded companies launching health related apps into the market. With players ranging from giants such as Tencent to true start-ups, most are expected to fail and and the ones remaining will have to hope that the government decides to trust in market forces rather than taking over itself.  [image: Digital Graphiti]

12-Mar-17 China has said its population will peak to 1.45 bn by 2030 and drop to 1.1 bn towards 2100, as it shrugged off concerns over a declining labour force. In 2016 China relaxed its One Child Policy amid concerns over a rapidly ageing population. Following the second-child policy, a total of 18.46 mn births were recorded across China in 2016. [image: The Siasat Daily]